XML 62 R21.htm IDEA: XBRL DOCUMENT v3.25.1
Shareholders’ Equity
12 Months Ended
Dec. 31, 2024
Shareholders’ Equity [Abstract]  
Shareholders’ Equity

14. Shareholders’ Equity

 

Ordinary Shares

 

As of December 31, 2024 and December 31, 2023, 31,904,468 and 23,940,000 ordinary shares were issued and outstanding, respectively. As of December 31, 2024 and December 31, 2023, nil preferred shares were issued and outstanding.

 

Completion of IPO

 

On February 18, 2022, the Company closed initial public offering (“IPO”) of 3,940,000 Ordinary Shares, par value US$0.0005 per share at a public offering price of $10.00 per share, and the Ordinary Shares started to trade on the Nasdaq Global Market under the ticker symbol “MHUA” on February 16, 2022. The Company sold 3,600,000 shares pursuant to our underwriters’ firm commitment, together with an additional 340,000 shares sold pursuant to the underwriters’ partial exercise of their over-allotment option.

Conversion of convertible loans

 

For the year ended December 31, 2024, the Company issued 7,964,468 ordinary shares upon the conversion of $6,000,000 of convertible debt with conversion prices ranging from $0.62 to $0.89 per share.

 

Warrants

 

As of December 31, 2024, there were 1,205,254 warrants outstanding and exercisable, exercise price of $2.9869 per share, which was related to warrants issued in connection of the Company’s convertible loans with fair value of $595,000. No warrants have been exercised for the year ended December 31, 2024.

 

The warrants were valued using the Black-Scholes model. The assumptions used to value the warrants were as follows:

 

  

As of
issue date

(Jan 2,
2024)

 
Share price  $1.4 
Exercise price  $2.9869 
Interest rate   3.93%
Time to maturity   5 years 
Volatility   59%

 

A summary of warrants activity for the December 31, 2024 was as follows:

 

   Number of
warrants
   Weighted
average
exercise
price
per
share
   Weighted
average
life
   Expiration
dates
 
       US$
per share
   Years     
Balance of warrants outstanding as of December 31, 2023   
-
    
-
    
          -
    
-
 
- warrants issued in connection with the convertible loans   1,205,254    2.9869    4    January 2, 2029 
Balance of warrants outstanding and exercisable as of December 31, 2024   1,205,254    2.9869    4      

 

Treasury Shares

 

For the year ended December 31, 2024, the Company repurchased an aggregate of 80,097 ordinary shares with total repurchase cost of $200,000, which was recorded as treasury shares. As of December 31, 2024, all these shares were held in an escrow account as reserve solely for potential future re-issuance.